PB Fintech IPO Proceeds Utilization Report for Q4FY26

PB Fintech Limited has submitted the Monitoring Agency Report for the quarter ended March 31, 2026, confirming no deviation in the utilization of IPO proceeds. Issued by ICICI Bank Limited, the report verifies that the funds have been applied strictly in accordance with the objects stated in the Offer Document. The disclosure, signed by Company Secretary and Compliance Officer Bhasker Joshi, was reviewed by the Audit Committee on May 06, 2026.

IPO Fund Raising Details

The company raised funds through a public issue that opened on November 1, 2021, and closed on November 3, 2021. Trading approval was received from NSE and BSE on November 12, 2021. The total issue size was INR 57,097.15 million, comprising a fresh issue and an offer for sale.

Parameter Details Mode of Fund Raising Public Issue Date of Raising Funds November 15, 2021 Total Issue Amount INR 57,097.15 Million Fresh Issue Amount INR 37,500.00 Million Offer for Sale Amount INR 19,597.15 Million Monitoring Agency ICICI Bank Limited Quarter Reported March 31, 2026 Deviation / Variation No

Object-wise Utilisation of Funds

The following table details the object-wise utilisation of the fresh issue proceeds (net of offer expenses) as at the end of the quarter ended March 31, 2026. The total revised allocation for the fresh issue stood at INR 36,126.85 million, which has been fully utilized.

Object Original Allocation (INR Million) Revised Allocation (INR Million) Funds Utilized (INR Million) Enhancing visibility and awareness of brands 15,000.00 15,000.00 15,000.00 New opportunities to expand growth initiatives 3,750.00 7,985.19 7,985.19 Funding Strategic investments and acquisitions 6,000.00 4,264.81 4,264.81 Expanding presence outside India 3,750.00 1,250.00 1,250.00 General corporate purposes 7,630.90 7,626.85 7,626.85 Total 36,130.90 36,126.85 36,126.85

Key Utilisation Notes

During the quarter ended March 31, 2026, the company utilized INR 1,902.04 million and INR 0.03 million through its subsidiaries Policybazaar Insurance Brokers Private Limited and Paisabazaar Marketing and Consulting Private Limited, respectively. Additionally, an overseas investment of INR 309.21 million was made in equity shares of M/s Genesis Group Limited via its wholly-owned subsidiary Icall Support Services Private Limited to support expansion outside India.

Modifications to the original allocations were approved by shareholders via special resolution on March 16, 2025. These included redirecting unutilized proceeds from strategic investments and international expansion towards new growth initiatives. The timeline for utilizing these funds was extended until March 31, 2026. The Monitoring Agency confirmed that all statutory approvals were obtained and no material deviations were observed.

PB Fintech Limited has informed the stock exchanges of a scheduled Analyst Day 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with applicable circulars and notifications. The intimation was filed on May 06, 2026, and signed by Bhasker Joshi, Company Secretary and Compliance Officer.

Analyst Meet Details

The company's management will participate in the investor conference as per the schedule outlined below:

Parameter: Details Date of Meeting: May 11, 2026 Event: PB Fintech Limited - Analyst Day 2026 Mode: Physical Location: PB Fintech Head Office at Plot No. 119, Sector-44, Gurugram- 122001, Haryana Time: 11:00 A.M. onwards (IST)

Regulatory Compliance and Disclosures

The intimation has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. PB Fintech has explicitly stated that no unpublished price sensitive information will be shared by the company during the aforesaid interaction. The company has also noted that the above schedule is subject to change due to exigencies on the part of the company or investors.

The intimation is available on the company's website at https://www.pbfintech.in/investor-relations . The filing was submitted to both the National Stock Exchange of India Limited and BSE Limited.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.